Zimmer Biomet - Noticias corporativas sobre dispositivos médicos


Zimmer Biomet B-Roll Footage

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. 

Zimmer Biomet B-Roll


Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger

WARSAW, Ind., March 30, 2015 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer") announced today that the European Commission ("EC") has conditionally cleared Zimmer's proposed acquisition of Biomet, Inc. ("Biomet").  The EC's clearance is conditioned upon Zimmer entering into agreements with a suitable buyer to divest certain assets comprising the remedy package previously submitted to the EC. 


Zimmer Holdings, Inc. Agrees to Sell $7.65 Billion of Senior Notes in Connection with Pending Merger with Biomet

WARSAW, Ind., March 11, 2015 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today that it has agreed to sell $7.65 billion of senior notes in an underwritten public offering through Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint book-running managers. 


Zimmer Holdings, Inc. and Biomet, Inc. Receive Requests for Additional Information from FTC

WARSAW, Ind., July 2, 2014 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer" or the "Company") and Biomet, Inc. ("Biomet") today announced that they have each received a request for additional information ("second request") from the United States Federal Trade Commission ("FTC") in connection with Zimmer's previously announced proposed acquisition of Biomet.  The second request was issued under the notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR Act").  


Zimmer Statement on European Commission Review of Biomet Merger

On June 11, 2014, the European Commission declared that the initial notification submitted for the Zimmer and Biomet merger is incomplete. Zimmer is working with the Commission to provide additional requested information and the Company expects to file an updated notification with the Commission in the near term. Zimmer continues to expect the transaction to be cleared and to close the merger in the first quarter of 2015.


Zimmer Holdings, Inc. to Combine with Biomet, Inc. in Transaction Valued at $13.35 Billion

WARSAW, Ind., April 24, 2014 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer" or the "Company") and Biomet, Inc.'s parent company ("Biomet") today announced that their respective Boards of Directors have approved a definitive agreement under which Zimmer will acquire Biomet in a cash and stock transaction valued at approximately $13.35 billion, including the assumption of net debt. The transaction, which is subject to customary closing conditions and regulatory approvals, is expected to close in the first quarter of 2015.